1. Home
  2. CTNT vs HCWB Comparison

CTNT vs HCWB Comparison

Compare CTNT & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheetah Net Supply Chain Service Inc.

CTNT

Cheetah Net Supply Chain Service Inc.

SELL

Current Price

$3.22

Market Cap

3.5M

Sector

N/A

ML Signal

SELL

Logo HCW Biologics Inc.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$1.17

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTNT
HCWB
Founded
2016
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
3.6M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
CTNT
HCWB
Price
$3.22
$1.17
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 32.7M
751.1K
Earning Date
11-06-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 57.74
N/A
EPS
★ N/A
N/A
Revenue
$1,288,536.00
★ $4,099,750.00
Revenue This Year
$78.50
$12,215.61
Revenue Next Year
$52.17
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 182.69
N/A
52 Week Low
$0.03
$0.86
52 Week High
$2,120.00
$25.44

Technical Indicators

Market Signals
Indicator
CTNT
HCWB
Relative Strength Index (RSI) 60.01 27.80
Support Level $2.95 $0.86
Resistance Level $4.18 $3.07
Average True Range (ATR) 0.34 0.12
MACD 0.19 -0.01
Stochastic Oscillator 72.83 9.93

Price Performance

Historical Comparison
CTNT
HCWB

About CTNT Cheetah Net Supply Chain Service Inc.

Cheetah Net Supply Chain Service Inc is a provider of logistics and warehousing services, historically in connection with the sale of parallel-import vehicles sourced in the U.S. to be sold in the PRC market, and more recently for the transportation of other goods between the U.S. and the PRC. Parallel-import vehicles in the PRC refer to automobiles purchased directly from overseas markets and imported for sale outside of the brand manufacturer's official distribution networks. The company operates as single report segment. The company operates in the USA and overseas.

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

Share on Social Networks: